IO Biotech, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $3.1M | $5.7M | $3.4M |
| FY2021 | $10.4M | $222.3M | $211.5M |
| FY2022 | $13.0M | $151.8M | $142.6M |
| FY2023 | $17.6M | $150.7M | $143.2M |
| FY2024 | $20.7M | $67.7M | $60.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $3.1M | $5.7M | $3.4M |
| FY2021 | $10.4M | $222.3M | $211.5M |
| FY2022 | $13.0M | $151.8M | $142.6M |
| FY2023 | $17.6M | $150.7M | $143.2M |
| FY2024 | $20.7M | $67.7M | $60.0M |